Sync template from atomicqms-style deployment

Policies/POL-001-Quality-Policy.md

@@ -0,0 +1,104 @@
+# Quality Policy - Clinical Outcome Measures Management
+
+| Document ID | POL-001 |
+|-------------|---------|
+| Title | Quality Policy - Clinical Outcome Measures Management |
+| Revision | 1.0 |
+| Effective Date | [DATE] |
+| Author | [AUTHOR] |
+| Approved By | [APPROVER] |
+
+---
+
+## 1. Policy Statement
+
+[ORGANIZATION NAME] is committed to maintaining the highest standards in clinical outcome measure development, validation, implementation, and data management. We ensure that all patient-reported outcomes (PROs), clinician-reported outcomes (ClinROs), observer-reported outcomes (ObsROs), and performance outcomes (PerfOs) used in our research and clinical programs meet rigorous psychometric standards and regulatory requirements.
+
+## 2. Quality Objectives
+
+Our organization commits to:
+
+1. **Scientific Rigor**: Ensuring all outcome measures demonstrate appropriate reliability, validity, responsiveness, and interpretability
+2. **Regulatory Compliance**: Maintaining compliance with FDA PRO Guidance, ICH guidelines, and other applicable regulations
+3. **Intellectual Property Protection**: Respecting copyright, licensing requirements, and intellectual property rights for all proprietary measures
+4. **Cultural Sensitivity**: Ensuring proper translation and linguistic validation for international use
+5. **Data Integrity**: Maintaining accurate scoring, data collection, and outcome assessment procedures
+6. **Training Excellence**: Ensuring all personnel are appropriately trained and certified in measure administration
+7. **Continuous Improvement**: Regularly reviewing and updating measure selection, validation, and implementation procedures
+
+## 3. Management Commitment
+
+Top management demonstrates commitment to clinical outcome measure quality by:
+
+- Ensuring adequate resources for psychometric validation studies
+- Supporting proper licensing and intellectual property management
+- Promoting evidence-based measure selection aligned with study objectives
+- Ensuring translation and linguistic validation follow ISPOR guidelines
+- Maintaining separation between clinical care and research assessments where appropriate
+- Supporting training and certification programs for measure administrators
+- Ensuring electronic clinical outcome assessment (eCOA) systems meet 21 CFR Part 11 requirements
+- Engaging with measure developers, copyright holders, and licensing organizations appropriately
+- Reviewing measure performance data and validation evidence regularly
+
+## 4. Scope
+
+This policy applies to:
+- All clinical outcome measures used in research studies
+- Patient-reported, clinician-reported, observer-reported, and performance outcomes
+- Psychometric validation activities
+- Measure licensing and copyright management
+- Translation and linguistic validation projects
+- Training and certification of measure administrators
+- Electronic and paper-based outcome assessment systems
+- Scoring algorithms and data interpretation procedures
+
+## 5. Key Principles
+
+### 5.1 Measure Selection
+- Select measures with demonstrated psychometric properties appropriate to the study population and objectives
+- Consider respondent burden, literacy requirements, and cultural appropriateness
+- Document rationale for measure selection with reference to published validation evidence
+- Obtain necessary licenses and permissions before use
+
+### 5.2 Psychometric Validation
+- Conduct validation studies following established methodologies (COSMIN, FDA PRO Guidance)
+- Document reliability (internal consistency, test-retest, inter-rater)
+- Establish validity (content, construct, criterion)
+- Assess responsiveness and minimal clinically important difference (MCID)
+- Generate normative data or reference values when appropriate
+
+### 5.3 Licensing & Copyright
+- Identify and track all proprietary measures requiring licenses
+- Maintain current license agreements and ensure compliance with terms
+- Track license renewal dates and usage restrictions
+- Document copyright attributions and obtain permissions for modifications
+- Manage royalty payments for commercial use
+
+### 5.4 Translation & Linguistic Validation
+- Follow ISPOR principles of good practice for translation and linguistic validation
+- Use forward-backward translation methodology
+- Conduct cognitive debriefing with target population
+- Obtain linguistic validation certificates
+- Maintain version control for all language versions
+
+### 5.5 Training & Certification
+- Ensure administrators are trained in measure-specific procedures
+- Document training completion and certification status
+- Maintain competency through periodic refresher training
+- Follow measure developer requirements for administrator qualifications
+
+## 6. Communication
+
+This policy shall be:
+- Communicated to all personnel involved in outcome measure activities
+- Available to study sponsors, regulatory authorities, and other stakeholders as appropriate
+- Reviewed annually for continuing suitability
+- Updated to reflect changes in regulatory requirements and scientific best practices
+
+---
+
+## Revision History
+
+| Rev | Date | Description | Author |
+|-----|------|-------------|--------|
+| 1.0 | [DATE] | Initial release | [AUTHOR] |